Encompass Health Corporation

EHC Healthcare Medical Care Facilities

Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024.

Revenue
+8.93%
EPS
+20.6%
Free cash flow
+52.3%
Total debt
+6.83%

Quarter to September 2026, against a year earlier

137.41 3.86 −2.73%
Market cap
$13.9B
P/E
21.8×
Fwd P/E
20.9×
Dividend yield
0.55%
F-score
7/9
Altman Z
3.25
Beneish M
−2.71
Dividend safety
77/100

Encompass Health Corporation (EHC) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Nov 6, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2026 P1I2: 3 added · 1 removed · 15 modified
P2I1A: no comparison — incorporated by reference
8-K Oct 28, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 13, 2026 8.01 Other events
10-Q Jun 30, 2026 P1I2: 5 added · 1 removed · 20 modified
P2I1A: no comparison — incorporated by reference
8-K Aug 5, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 29, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K May 14, 2026 1.01 Entry into a material definitive agreement; 8.01 Other events; 9.01 Financial statements and exhibits
8-K May 7, 2026 5.07 Submission of matters to a vote of security holders
10-Q Mar 31, 2026
8-K Apr 30, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 9, 2026 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 16 added · 9 removed · 64 modified
1A: 6 added · 5 removed · 83 modified
7: 9 added · 10 removed · 53 modified
8-K/A Feb 19, 2026 5.02 Departure or appointment of directors or officers
8-K Feb 5, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 30, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits Officer departure
8-K Dec 1, 2025 7.01 Regulation FD disclosure
10-Q Sep 30, 2025
8-K Oct 29, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 17, 2025 5.02 Departure or appointment of directors or officers
8-K Sep 12, 2025 7.01 Regulation FD disclosure
10-Q Jun 30, 2025
8-K Aug 4, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K Apr 24, 2025 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 6, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Oct 28, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 5, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Apr 24, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Feb 7, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.